Virso (400 mg) [Sofosbuvir] & DACTOVIN – DACLATASVIR TABLET 60 MG – COMBO

Virso (400 mg) [Sofosbuvir]
The main active ingredient or salt in Virso (400 mg) is Sofosbuvir.

Sofosbuvir (International brand name Sovaldi) is used along with ribavirin (Copegus, Rebetol) and sometimes another medication (peginterferon alfa – Pegasys) to treat chronic hepatitis C (an ongoing viral infection that damages the liver). Sofosbuvir is also used along with ribavirin (Copegus, Rebetol) in people with liver cancer and hepatitis C infection who are waiting for a liver transplant to treat hepatitis C infection and to decrease the risk of reinfection after the transplant. Sofosbuvir is in a class of antiviral medications called nucleotide polymerase inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Sofosbuvir may not prevent the spread of hepatitis C to other people. In comparison to hepatitis C virus treatment in the past, sofosbuvir-based regimens provide a higher cure rate, fewer side effects, and a 2-4 times reduced duration of therapy. Sofosbuvir allows most people to be treated successfully without the use of peginterferon, an injectable drug with severe side effects that is a key component of older drug combinations for the treatment of hepatitis C virus.

Enquiry sofosbuvir medicines online 

DACTOVIN – DACLATASVIR TABLET 60 MG

Dactovin contains generic salt content Daclatasvir. Dactovin is available in tablets form. Dactovin is manufactured by Strides Shasun Limited.

Note:

Dactovin is a prescription drug and should be used under proper medical guidance and advice. Keep all medicines out of the reach of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.

The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.